Return to homepagePandemic Pact

SARS2BlockEntry Construction of nano-ligands to block entry of SARS-CoV-2]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $243,924.36

  • Funder

    Other funders (France)

  • Principal Investigator

    Bernard DELMAS

  • Research Location

    France

  • Lead Research Institution

    Institut national de recherche pour l?agriculture, l?alimentation et l?environnement, Jouy-en-Josas

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The SARS2BlockEntry project aims to develop molecules, nanoligands, capable of neutralizing the Sars-CoV-2 virus and preventing it from multiplying in lung cells. These nanoligands could make it possible to obtain antivirals capable of targeting SARS-CoV-2.